Nervine herbs for treating anxiety

Alternative and Complementary Therapies

Volumn 10, Issue 6, 2004, Pages 309-315

  Abascal, Kathy ^a   Yarnell, Eric ^a,b  

^a Botanical Medicine Academy   (United States)

^b BASTYR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; AVENA EXTRACT; CRATAEGUS EXTRACT; DIGOXIN; ESCHSCHOLTZIA CALIFORNICA EXTRACT; HYPERICUM EXTRACT; KAVA EXTRACT; LAVANDULA EXTRACT; LEONURIS CARDIACA EXTRACT; MATRICARIA RECUITA EXTRACT; MELISSA OFFICINALIS EXTRACT; MONOAMINE OXIDASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PAPAVER SOMNIFERUM EXTRACT; PASSIFLORA EDULIS EXTRACT; PASSIFLORA INCARNATA EXTRACT; PLANT EXTRACT; PROTEINASE INHIBITOR; SCUTELLARIA LATERIFLORA EXTRACT; SEDATIVE AGENT; TILIA EXTRACT; UNCLASSIFIED DRUG; VALERIANA EXTRACT; VERBENA EXTRACT; WARFARIN;

ANALGESIC ACTIVITY; ANXIETY DISORDER; BLOOD PRESSURE; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; HAMILTON SCALE; HERB; HUMAN; INSOMNIA; MEDICAL PRACTICE; NONHUMAN; REVIEW; SELF EVALUATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TACHYCARDIA;

EID: 10644224333     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.2004.10.309     Document Type: Review

References (40)

1. Hanus M, Lafon J, Matheiu M. Double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Op 2004;20:63-71.
2. Online document at: www.paniccenter.net/professional/about/ Accessed August 2004.
3. Weiss RF. Herbal Medicine. Beaconsfield, UK: Beaconsfield Publishers Ltd., 1988.
4. Rolland A, Fleurentin J, Lanhers MC, et al. Neurophysiological effects of an extract of Eschscholzia californica Cham (Papaveraceae). Phytother Res 2001;15:377-381.
5. Kim SR, Hwang SY, Jang YP, et al. Protopine from Corydalis ternate has anticholinesterase and antiamnesic activities. Planta Med 1999;65:218-221.
6. Skenderi G. Herbal Vade Mecum. Rutherford, NJ: Herbacy Press, 2004.
7. Blumenthal M, Busse WR, Goldberg A, et al. The Complete German Commission E Monographs. Boston, MA: Integrative Medicine Communications, 1998.
8. Felter HW. The Eclectic Materia Medica, Pharmacology and Therapeutics. Sandy, OR: Eclectic Medical Publications, 1994.
9. Schmidt K, Geckeler K. Pharmacotherapy with Avena sativa: A double-blind study. Int J Clin Pharmacol Biopharm 1976;14:214-216.
10. Bye C, Fowle ASE, Letley E, Wilkinson S. Lack of effect of Avena sativa on cigarette smoking. Nature 1974;252:580-581.
11. Akhondzadeh S, Kashani L, Mobaseri M, et al. Passionflower in the treatment of opiates withdrawal: A double-blind randomized controlled trial. J Clin Pharm Ther 2001;6:369-373.
12. Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001;26:363-367.
13. Dhawan K. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata - a brief perspective. Addiction Biol 2003;8:379-386.
14. Dhawan K, Kumar S, Sharma A. Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata Linn. in mice. Phytother Res 2003;17:401-403.
15. Petry RD, Reginatto F, De-Paris F, et al. Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves. Phytother Res 2001;15:162-164.
16. Capasso A, Pinto A. Experimental investigations of the synergistic-sedative effect of passiflora and kava. Acta Ther 1995;21:127-140.
17. Burkard W, Kopp B, Krenn L, et al. Receptor binding studies in the CNS with extracts of Passiflora incarnata. Pharmaceut Pharmacol Lett 1997;7:25-26.
18. Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia 2001;72:698-702.
19. Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. J Toxicol 2000;38:63-66.
20. Maluf E, Barros HMT, Frochtengarten ML, et al. Assessment of the hypnotic/sedative effects and toxicity of Passiflora edulis aqueous extract in rodents and humans. Phytother Res 1991;5:262-266.
21. Kennedy DO, Scholey AB, Tildesley NTJ, et al. Modulation of mood and cognitive performance following acute administration of Melissa officinails (lemon balm). Pharmacol Biochem Behav 2002;72:952-964.
22. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized, placebo controlled trial. J Neurol Neurosurg Psych 2003;74:863-866.
23. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychol 2002;63:553-558.
24. Soulimani R, Fleurentin J, Mortier F, et al. Neurotropic action of the hydroethanolic extract of Melissa officinalis in the mouse. Planta Med 1991;57:105-109.
25. Santini F, Vitti P, Ceccarini G, et al. In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 2003;26:950-955.
26. Yarnell E, Abascal K, Hooper CG. Clinical Botanical Medicine. Larchmont, NY, Mary Ann Liebert, Inc., 2003.
27. Online document at: www.bastyr.edu/academic/botmed/herbs.asp?Herbld= 1052500779 Accessed August 2004.
28. Hernandez NE, Tereschuk ML, Abdala LR. Antimicrobial activity of flavonoids in medicinal plants from Tafi del Valle (Tucuman, Argentina). J Ethnopharmacol 2000;73(1-2):317-322.
29. Li Y, Ishibashi M, Satake M, et al. Sterol and triterpenoid constituents of Verbena littoralis with NGF-potentiating activity. J Nat Prod 2003;66:696-698.
30. Li YS, Matsunaga K, Kato R, Ohizumi Y. Verbenachalcone, a novel dimeric dihydrochalcone with potentiating activity on nerve growth factor-action from Verbena littoralis. J Nat Prod 2001;64:806-808.
31. Li YS, Matsunaga K, Kato R, Ohizumi Y. Potentiation of nerve growth factor-induced elongation of neurties by gelsemiol and 9-ydroxysemperoside aglucone in PC12D cells. J Pharm Pharmacol 2001;53:915-919.
32. Moore M. Medicinal Plants of the Mountain West. Santa Fe: Museum of New Mexico Press, 2003.
33. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and species [sic]. Proc Soc Exp Biol Med 1998;217:369-378.
34. Fry KK, Wingo CJ, Amagase H. Alternative to hormone replacement therapy with herbal formula, Estro-Logic for prevention, mitigation, and treatment of symptoms caused by the estrogenic hormonal imbalance in the patients. FASEB J 2004;18(4-5):Abstr 368.3
35. Czygan FC. Linden (Tilia spp.)-Linden flowers. Zeitschr Phytother 1997;18:242-246.
36. Aydin S, Ozturk Y, Baser KHC, Kirimer N. Effects of Alcea pallida L.(A.) and Tilia argentea Desf. ex DC infusions on swimming performance in mice. Phytother Res 1992;6:219-220.
37. Viola H, Wolfman C, Levi de Stein M, et al. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tormontosa (Tiliaceae). J Ethnopharmacol 1994;44:47-53.
38. Coleta M, Campos MG, Cotrim MD, da Cunha AP. Comparative evaluation of Melissa officinalis L, Tilia europaea L, Passiflora edulis Sims. and Hypericum perforatum L. in the elevated plus maze anxiety test. Pharmacopsychology 2001;34(suppl1):S20-S21.
39. Lanza JP, Steinmetz MD, Lavaivre-Pierlovisi M. Pharmacodynamic action and toxicity of aqueous extracts of lime tree Tilia sylvestris [in French]. Plantes Med Phytoter 1982;16:129-136.
40. Anesini C, Werner S, Borda E. Effect of Tilia cordata flower on lymphocyte proliferation: Participation of peripheral type benzodiazepine binding sites. Fitoterapia 1999;70:361-367.